These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 26055620)

  • 1. Pharmacokinetics and Metabolism of Delamanid, a Novel Anti-Tuberculosis Drug, in Animals and Humans: Importance of Albumin Metabolism In Vivo.
    Sasahara K; Shimokawa Y; Hirao Y; Koyama N; Kitano K; Shibata M; Umehara K
    Drug Metab Dispos; 2015 Aug; 43(8):1267-76. PubMed ID: 26055620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic Mechanism of Delamanid, a New Anti-Tuberculosis Drug, in Human Plasma.
    Shimokawa Y; Sasahara K; Koyama N; Kitano K; Shibata M; Yoda N; Umehara K
    Drug Metab Dispos; 2015 Aug; 43(8):1277-83. PubMed ID: 26055621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preclinical pharmacokinetics and metabolism of 6-(4-(2,5-difluorophenyl)oxazol-5-yl)-3-isopropyl-[1,2,4]-triazolo[4,3-a]pyridine, a novel and selective p38alpha inhibitor: identification of an active metabolite in preclinical species and human liver microsomes.
    Kalgutkar AS; Hatch HL; Kosea F; Nguyen HT; Choo EF; McClure KF; Taylor TJ; Henne KR; Kuperman AV; Dombroski MA; Letavic MA
    Biopharm Drug Dispos; 2006 Nov; 27(8):371-86. PubMed ID: 16944451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absorption, distribution and excretion of the anti-tuberculosis drug delamanid in rats: Extensive tissue distribution suggests potential therapeutic value for extrapulmonary tuberculosis.
    Shibata M; Shimokawa Y; Sasahara K; Yoda N; Sasabe H; Suzuki M; Umehara K
    Biopharm Drug Dispos; 2017 May; 38(4):301-312. PubMed ID: 28092695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delamanid Coadministered with Antiretroviral Drugs or Antituberculosis Drugs Shows No Clinically Relevant Drug-Drug Interactions in Healthy Subjects.
    Mallikaarjun S; Wells C; Petersen C; Paccaly A; Shoaf SE; Patil S; Geiter L
    Antimicrob Agents Chemother; 2016 Oct; 60(10):5976-85. PubMed ID: 27458223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delamanid for multidrug-resistant pulmonary tuberculosis.
    Gler MT; Skripconoka V; Sanchez-Garavito E; Xiao H; Cabrera-Rivero JL; Vargas-Vasquez DE; Gao M; Awad M; Park SK; Shim TS; Suh GY; Danilovits M; Ogata H; Kurve A; Chang J; Suzuki K; Tupasi T; Koh WJ; Seaworth B; Geiter LJ; Wells CD
    N Engl J Med; 2012 Jun; 366(23):2151-60. PubMed ID: 22670901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delamanid is not metabolized by Salmonella or human nitroreductases: A possible mechanism for the lack of mutagenicity.
    Hanaki E; Hayashi M; Matsumoto M
    Regul Toxicol Pharmacol; 2017 Mar; 84():1-8. PubMed ID: 27988333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolism and pharmacokinetics of 3-n-butylphthalide (NBP) in humans: the role of cytochrome P450s and alcohol dehydrogenase in biotransformation.
    Diao X; Deng P; Xie C; Li X; Zhong D; Zhang Y; Chen X
    Drug Metab Dispos; 2013 Feb; 41(2):430-44. PubMed ID: 23169608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Excretion, metabolism, and pharmacokinetics of CP-945,598, a selective cannabinoid receptor antagonist, in rats, mice, and dogs.
    Miao Z; Scott DO; Griffith DA; Day R; Prakash C
    Drug Metab Dispos; 2011 Dec; 39(12):2191-208. PubMed ID: 21875952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of Human Pharmacokinetic Profiles of the Antituberculosis Drug Delamanid from Nonclinical Data: Potential Therapeutic Value against Extrapulmonary Tuberculosis.
    Shibata M; Masuda M; Sasahara K; Sasabe H; Sasaki T; Kim S; Takeuchi K; Umehara K; Kashiyama E
    Antimicrob Agents Chemother; 2021 Jul; 65(8):e0257120. PubMed ID: 34097484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of bedaquiline and delamanid in diabetes patients: clinical and pharmacological considerations.
    Hu M; Zheng C; Gao F
    Drug Des Devel Ther; 2016; 10():3983-3994. PubMed ID: 27994440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delamanid (OPC-67683) for treatment of multi-drug-resistant tuberculosis.
    Sotgiu G; Pontali E; Centis R; D'Ambrosio L; Migliori GB
    Expert Rev Anti Infect Ther; 2015 Mar; 13(3):305-15. PubMed ID: 25645397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biotransformation of 6-methoxy-3-(3',4',5'-trimethoxy-benzoyl)-1H-indole (BPR0L075), a novel antimicrotubule agent, by mouse, rat, dog, and human liver microsomes.
    Yao HT; Wu YS; Chang YW; Hsieh HP; Chen WC; Lan SJ; Chen CT; Chao YS; Chang L; Sun HY; Yeh TK
    Drug Metab Dispos; 2007 Jul; 35(7):1042-9. PubMed ID: 17403915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population Pharmacokinetics of Delamanid and its Main Metabolite DM-6705 in Drug-Resistant Tuberculosis Patients Receiving Delamanid Alone or Coadministered with Bedaquiline.
    Tanneau L; Karlsson MO; Diacon AH; Shenje J; De Los Rios J; Wiesner L; Upton CM; Dooley KE; Maartens G; Svensson EM
    Clin Pharmacokinet; 2022 Aug; 61(8):1177-1185. PubMed ID: 35668346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple species metabolism of PHA-568487, a selective alpha 7 nicotinic acetylcholine receptor agonist.
    Shilliday FB; Walker DP; Gu C; Fang X; Thornburgh B; Fate GD; Daniels JS
    Drug Metab Lett; 2010 Aug; 4(3):162-72. PubMed ID: 20642449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delamanid Central Nervous System Pharmacokinetics in Tuberculous Meningitis in Rabbits and Humans.
    Tucker EW; Pieterse L; Zimmerman MD; Udwadia ZF; Peloquin CA; Gler MT; Ganatra S; Tornheim JA; Chawla P; Caoili JC; Ritchie B; Jain SK; Dartois V; Dooley KE
    Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31383662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The anti-tubercular drug delamanid as a potential oral treatment for visceral leishmaniasis.
    Patterson S; Wyllie S; Norval S; Stojanovski L; Simeons FR; Auer JL; Osuna-Cabello M; Read KD; Fairlamb AH
    Elife; 2016 May; 5():. PubMed ID: 27215734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delamanid for the treatment of pulmonary multidrug-resistant tuberculosis.
    Thakare R; Soni I; Dasgupta A; Chopra S
    Drugs Today (Barc); 2015 Feb; 51(2):117-23. PubMed ID: 25756067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regiospecific and stereospecific triangulation of the structures of metabolites formed by sequential metabolism at multiple prochiral centers.
    Greene RJ; Davis JA; Subramanian R; Deane MR; Emery MG; Slatter JG
    Drug Metab Dispos; 2012 May; 40(5):928-42. PubMed ID: 22328582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative metabolism of 14C-labeled apixaban in mice, rats, rabbits, dogs, and humans.
    Zhang D; He K; Raghavan N; Wang L; Mitroka J; Maxwell BD; Knabb RM; Frost C; Schuster A; Hao F; Gu Z; Humphreys WG; Grossman SJ
    Drug Metab Dispos; 2009 Aug; 37(8):1738-48. PubMed ID: 19420130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.